Future Neurology provides a forum to address the most important challenges and advances in modern neurology and neuropsychiatry, highlighting their relevance in the clinical setting. The journal provides authoritative commentary and analysis to draw attention rapidly, clearly and concisely to the key scientific and clinical issues. The journal includes news and views, full review articles, clinical research, literature awareness, concise commentary and analysis, and reports from the conference circuit.
Topics addressed include:
- Adverse events and drug safety
- Profiles of new neurotherapeutic agents
- Biological processes involved in neurological dysfunction and how new understanding will impact treatment
- Disease risk assessment
- Clinical implications and applications for new biomarkers
- Impact of molecular genetics on prevention, screening, diagnosis and treatment
- Integration of diagnostic and therapeutic approaches
- New therapeutic targets
- Pharmacoeconomics and cost–benefit issues in neurology
- Potential applications of stem cells and gene therapy in neurodegenerative diseases
Articles are subject to peer-review by three independent referees on a double-blind basis. Authors publishing in the journal are asked to disclose any professional or financial interest that may be perceived as causing a conflict of interest in the context of the article.
The journal welcomes unsolicited article proposals.
